Cargando…

Melatonin Alleviates PM(2.5)-Induced Hepatic Steatosis and Metabolic-Associated Fatty Liver Disease in ApoE(−/−) Mice

BACKGROUND: Exposure to fine particulate matter (PM(2.5)) is associated with the risk of developing metabolic-associated fatty liver disease (MAFLD). Melatonin is the main secreted product of the pineal gland and has been reported to prevent hepatic lipid metabolism disorders. However, it remains un...

Descripción completa

Detalles Bibliográficos
Autores principales:	Du, Zhou, Liang, Shuang, Li, Yang, Zhang, Jingyi, Yu, Yang, Xu, Qing, Sun, Zhiwei, Duan, Junchao
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2022
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9200552/ https://www.ncbi.nlm.nih.gov/pubmed/35720187 http://dx.doi.org/10.1155/2022/8688643

Ejemplares similares

Melatonin ameliorates PM(2.5)‐induced cardiac perivascular fibrosis through regulating mitochondrial redox homeostasis
por: Jiang, Jinjin, et al.
Publicado: (2020)

The critical role of epigenetic mechanism in PM(2.5)-induced cardiovascular diseases
por: Sun, Qinglin, et al.
Publicado: (2021)

Repeat dose exposure of PM(2.5) triggers the disseminated intravascular coagulation (DIC) in SD rats
por: Liang, Shuang, et al.
Publicado: (2019)

The mitochondria-targeted antioxidant MitoQ attenuated PM(2.5)-induced vascular fibrosis via regulating mitophagy
por: Ning, Ruihong, et al.
Publicado: (2021)

Melatonin: a potential intervention for hepatic steatosis
por: Sun, Hang, et al.
Publicado: (2015)

BuShenKangShuai Tablet Alleviates Hepatic Steatosis via Improving Liver Adiponectin Resistance in ApoE(−/−) Mice
por: Pang, Shu-chao, et al.
Publicado: (2019)

Inhalation Exposure to PM(2.5) Counteracts Hepatic Steatosis in Mice Fed High-fat Diet by Stimulating Hepatic Autophagy
por: Qiu, Yining, et al.
Publicado: (2017)

Astragalus Flavone Ameliorates Atherosclerosis and Hepatic Steatosis Via Inhibiting Lipid-Disorder and Inflammation in apoE(−/−) Mice
por: Ma, Chuanrui, et al.
Publicado: (2020)

Astaxanthin alleviates PM(2.5)-induced cardiomyocyte injury via inhibiting ferroptosis
por: Ren, Jingyi, et al.
Publicado: (2023)

Effect of Melatonin as an Antioxidant Drug to Reverse Hepatic Steatosis: Experimental Model
por: Martínez Soriano, Blanca, et al.
Publicado: (2020)

TRIF Differentially Regulates Hepatic Steatosis and Inflammation/Fibrosis in Mice
por: Yang, Ling, et al.
Publicado: (2017)

Canagliflozin Attenuates Hepatic Steatosis and Atherosclerosis Progression in Western Diet-Fed ApoE-Knockout Mice
por: Zuo, Qingjuan, et al.
Publicado: (2022)

Sesamol Alleviates Obesity-Related Hepatic Steatosis via Activating Hepatic PKA Pathway
por: Xu, Hai-Yan, et al.
Publicado: (2020)

NAMPT overexpression alleviates alcohol-induced hepatic steatosis in mice
por: Xiong, Xiwen, et al.
Publicado: (2019)

Alleviation of Hepatic Steatosis by Alpha-Defensin Is Associated with Enhanced Lipolysis
por: Maraga, Emad, et al.
Publicado: (2023)

Silica nanoparticles trigger hepatic lipid-metabolism disorder in vivo and in vitro
por: Duan, Junchao, et al.
Publicado: (2018)

Apple Polyphenols Decrease Atherosclerosis and Hepatic Steatosis in ApoE(−/−) Mice through the ROS/MAPK/NF-κB Pathway
por: Xu, Zhe-Rong, et al.
Publicado: (2015)

Melatonin ameliorates hepatic steatosis by inhibiting NLRP3 inflammasome in db/db mice
por: Yu, Yongxiang, et al.
Publicado: (2021)

Effects of Fine Particulate Matter (PM(2.5)) on Systemic Oxidative Stress and Cardiac Function in ApoE(−/−) Mice
por: Pei, Yiling, et al.
Publicado: (2016)

PM2.5 exposure induces vascular dysfunction via NO generated by iNOS in lung of ApoE-/- mouse
por: Long, Min-Hui, et al.
Publicado: (2020)

Effects of coal-fired PM(2.5) on the expression levels of atherosclerosis-related proteins and the phosphorylation level of MAPK in ApoE(−/−) mice
por: Wang, Siqi, et al.
Publicado: (2020)

PPDPF alleviates hepatic steatosis through inhibition of mTOR signaling
por: Ma, Ning, et al.
Publicado: (2021)

PM(2.5) and Dementia in a Low Exposure Setting: The Influence of Odor Identification Ability and APOE
por: Andersson, John, et al.
Publicado: (2023)

Dapagliflozin Alleviates Hepatic Steatosis by Restoring Autophagy via the AMPK-mTOR Pathway
por: Li, Liuran, et al.
Publicado: (2021)

Nonalcoholic fatty liver disease: molecular mechanisms for the hepatic steatosis
por: Koo, Seung-Hoi
Publicado: (2013)

Hepatic Reduction in Cholesterol 25-Hydroxylase Aggravates Diet-induced Steatosis
por: Dong, Zeyu, et al.
Publicado: (2022)

Baicalein Prevents Fructose-Induced Hepatic Steatosis in Rats: In the Regulation of Fatty Acid De Novo Synthesis, Fatty Acid Elongation and Fatty Acid Oxidation
por: Li, Pan, et al.
Publicado: (2022)

PM(2.5)-Associated Hospitalization Risk of Cardiovascular Diseases in Wuhan: Cases Alleviated by Residential Greenness
por: Yang, Haomin, et al.
Publicado: (2022)

Cannabinoid receptor 1 knockout alleviates hepatic steatosis by downregulating perilipin 2
por: Irungbam, Karuna, et al.
Publicado: (2019)

Interleukin-6 mediated exercise-induced alleviation of adiposity and hepatic steatosis in mice
por: Li, Long, et al.
Publicado: (2021)

Liraglutide Alleviates Hepatic Steatosis by Activating the TFEB-Regulated Autophagy-Lysosomal Pathway
por: Fang, Yunyun, et al.
Publicado: (2020)

Follistatin Alleviates Hepatic Steatosis in NAFLD via the mTOR Dependent Pathway
por: Tong, Junlu, et al.
Publicado: (2022)

Vitamin D improves hepatic steatosis in NAFLD via regulation of fatty acid uptake and β-oxidation
por: Du, Tingwan, et al.
Publicado: (2023)

APOE Peripheral and Brain Impact: APOE4 Carriers Accelerate Their Alzheimer Continuum and Have a High Risk of Suicide in PM(2.5) Polluted Cities
por: Calderón-Garcidueñas, Lilian, et al.
Publicado: (2023)

Potential injurious effects of the fine particulate PM2.5 on the progression of atherosclerosis in apoE-deficient mice by activating platelets and leukocytes
por: Zhu, Xuecan, et al.
Publicado: (2018)

TFE3 Alleviates Hepatic Steatosis through Autophagy-Induced Lipophagy and PGC1α-Mediated Fatty Acid β-Oxidation
por: Xiong, Jie, et al.
Publicado: (2016)

Novel PPARα agonist MHY553 alleviates hepatic steatosis by increasing fatty acid oxidation and decreasing inflammation during aging
por: Kim, Seong Min, et al.
Publicado: (2017)

Distinct AMPK-Mediated FAS/HSL Pathway Is Implicated in the Alleviating Effect of Nuciferine on Obesity and Hepatic Steatosis in HFD-Fed Mice
por: Xu, Hanyuan, et al.
Publicado: (2022)

Change in skeletal muscle mass is associated with hepatic steatosis in nonalcoholic fatty liver disease
por: Jo, Ik Hyun, et al.
Publicado: (2023)

Diminazene Aceturate Stabilizes Atherosclerotic Plaque and Attenuates Hepatic Steatosis in apoE-Knockout Mice by Influencing Macrophages Polarization and Taurine Biosynthesis
por: Stachowicz, Aneta, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_t1afjgit5o5javr0ef4ud90kqh